News About: Pharm. Industry


No place for illegal rebates using ‘CSOs,’ harming ethical business management

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) gave a strong warning message against illegal rebate activities using CSOs(Contract Sales Organization) and expressed concerns about it. The KP...

FIP Seoul Conference creates foundation for Korean pharmacists’ globalization and advancement

2017 FIP Seoul Conference and World Congress of Pharmacy and Pharmaceutical Sciences in Seoul, the world’s largest event for pharmacists, will be held between the 10th and 14th of September at Seoul COEX Convention Ce...

KOSPI and KOSDAQ records respective ‘large decrease’ and ‘large increase’ in net profit

The KOSPI listed pharmaceutical companies’ average net profits of the 1st quarter recorded a negative figure compared to the same quarter of the last year, but the ones of KOSDAQ listed pharmaceutical companies went u...

Series of IPOs at the end of the year

Starting with DongKoo Bio&Pharma, a series of pharmaceutical companies are expected to go public. According to the pharmaceutical industry, unlisted pharmaceutical companies, such as DongKoo Bio&Pharma, CJ HealthCare...

KOSDAQ’s 1st quarter sales growth rate 4 times higher than KOSPIA

It was observed the KOSDAQ listed pharmaceutical companies’ year-on-year average sales growth rate of the 1st quarter was 4 times higher than the ones of KOSPI listed pharmaceutical companies. On the other hand, KOSPI...

Listed pharmas very ‘decent’ in financial soundness

Although most listed pharmaceutical companies were evaluated decent in financial soundness, but 1 of 5 listed pharmaceuticals have a poor financial structure with a debt ratio close to 100%. According to the Yakup Sh...

Court rules probation on pharmaceutical company chairman for tax evasion

On the 29th, the Seoul Central District Court ruled 2 years and 6 months of prison and 3 years of probation on a pharmaceutical company chairman for approximately KRW 3.6 billion tax evasion using stocks issued for a ...

Listed pharmas focusing on cashable assets due to uncertainty followed by political turnover

Due to uncertainty caused by the political turnover, listed pharmaceutical companies were analyzed to focus on securing cashable assets. According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and K...

1 of 3 listed pharmas record operating profit rate more than 10%

1 of 3 listed pharmaceutical companies recorded an operating profit rate more than 10%, but there were also about 10 companies having the rate approximately at 3%, which showed the intensified polarization in profitab...

Prosecutor’s investigation tightens pharmas and wholsalers

Pharmaceutical distribution companies have been sharply tense. This is because the prosecution’s rebate investigation seems to continue. Even on the 30th when a result of investigation targeting a specific pharmaceu...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.